Trial intelligence / Profile preview

IMDIAB XIII: Calcitriol versus placebo in recent-onset type 1 diabetes mellitus

2005-000751-15Phase 3Active

Sponsor
Università Campus Bio-Medico di Roma
Start
Jul 2005
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Calcitriol with Placebo (2 arms). Primary endpoints: Glycometabolic control and Endogenous insulin secretion. Started Jul 2005; status: active.

02

Drugs

calcitriol
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2005-000751-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000751-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call